‘The growth phase in pharma will come back in FY 19’ET.com Mutual Funds spoke to Sonam Udasi, Fund Manager, Tata India Pharma & HealthCare Fund, to find out what is in store for the sector.
Obamacare repeal on the ropes as pivotal Republican rebuffs Donald TrumpThe most moderate of Republican senators joined John McCain and Rand Paul in rejecting the bill to end Obamacare.
For those waiting to invest in this market, a correction won’t come easily: Nilesh ShahWe need to accept that this market is no longer a cheap market, as it was in 2013, or as it was in the middle of 2008, says the MD of Kotak...